| # | Country | Total Patents | |
|---|---|---|---|
| #1 | China | 11 | |
| #2 | EPO (European Patent Office) | 10 | |
| #3 | Australia | 8 | |
| #4 | Brazil | 8 | |
| #5 | Canada | 8 | |
| #6 | Republic of Korea | 8 | |
| #7 | WIPO (World Intellectual Property Organization) | 8 | |
| #8 | Israel | 7 | |
| #9 | Taiwan | 7 | |
| #10 | Singapore | 6 | |
| #11 | United States | 4 | |
| #12 | Hong Kong | 2 | |
| #13 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Heterocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Chen Li | 71 |
| #2 | Li Yongguo | 54 |
| #3 | Wang Gaosen | 52 |
| #4 | Gao Huisheng | 36 |
| #5 | Wu Chengde | 9 |
| #6 | Li Chen | 9 |
| #7 | Yongguo Li | 7 |
| #8 | Gaosen Wang | 7 |
| #9 | Duan Yuejiao | 7 |
| #10 | She Jin | 7 |
| Publication | Filing date | Title |
|---|---|---|
| KR20210016420A | Pharmaceutical combinations, compositions, and combination preparations comprising glucokinase activator and SGLT-2 inhibitor, and preparation method and use thereof | |
| CN109646404A | Oral preparation of glucokinase activators and preparation method thereof | |
| US2018318254A1 | Substituted pyrrolidines as mGluR5 antagonists | |
| US2019100506A1 | Pyrrole derivatives | |
| EP3400220A1 | Pyrazole derivatives | |
| WO2014124560A1 | Mglur regulators |